Long-term survival and clinical outcomes following direct-acting antiviral (DAA) treatment in HCV decompensated cirrhosis in Brazil: a real-world study-Reference-Cited by-同舟云学术

Long-term survival and clinical outcomes following direct-acting antiviral (DAA) treatment in HCV decompensated cirrhosis in Brazil: a real-world study

Published:2022-09 Issue:5 Volume:26 Page:102697
ISSN:1413-8670
Container-title:The Brazilian Journal of Infectious Diseases
language:en
Short-container-title:The Brazilian Journal of Infectious Diseases

Author:

Pereira Gustavo H.^ORCID,Peixoto Helena R.^ORCID,Giusti Mariana L.^ORCID,Souza Mariana L.^ORCID,Victor Livia B.^ORCID,Fernandes Flávia^ORCID,Perez Renata M.^ORCID,Villela-Nogueira Cristiane A.^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference31 articles.

1. The combination of simeprevir and sofosbuvir is more effective than that of peginterferon, ribavirin, and sofosbuvir for patients with hepatitis C-related Child's class A cirrhosis;Pearlman;Gastroenterology,2015

2. Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: an integrated safety and efficacy analysis;Reddy;Hepatology,2015

3. Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis;Aqel;Hepatology,2015

4. Safety and efficacy of simeprevir/sofosbuvir in hepatitis C-infected patients with compensated and decompensated cirrhosis;Saxena;Hepatology,2015

5. Direct antiviral therapy for treatment of hepatitis C: a real-world study from Brazil;Lobato;Ann Hepatol,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct-Acting Antiviral Therapy for Patients with Chronic Hepatitis C Infection and Decompensated Cirrhosis;Digestive Diseases and Sciences;2024-04-05

2. Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation;Hepatology International;2024-02-28

3. Five-year follow-up of sustained virological response with hepatitis C infection after direct-acting antiviral therapy: A single-center retrospective study;Medicine;2024-02-16

4. Serologic screening for viral infections among blood donors: a study in a blood bank in southern Brazil;Revista da Associação Médica Brasileira;2024

5. Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus;Journal of Gastroenterology;2023-10-13